Bentham Science Logo

Most Accessed Articles

An Overview of Targeted Alpha Therapy with 225Actinium and 213Bismuth

, 2018; 11(3): 200-208.

Alfred Morgenstern*, Christos Apostolidis, Clemens Kratochwil, Mike Sathekge, Leszek Krolicki and Frank Bruchertseifer


DOI: 10.2174/1874471011666180502104524


Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma

, 2018; 11(1): 14-21.

Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*


DOI: 10.2174/1874471011666171215093112



Development of 225Ac Radiopharmaceuticals: TRIUMF Perspectives and Experiences

, 2018; 11(3): 156-172.

Andrew Kyle Henderson Robertson, Caterina Fortunata Ramogida, Paul Schaffer and Valery Radchenko*


DOI: 10.2174/1874471011666180416161908



PET/CT With 68Ga-PSMA in Prostate Cancer: Radiopharmaceutical Background and Clinical Implications

, 2018; 11(1): 4-13.

Giampiero Giovacchini*, Elisabetta Giovannini, Mattia Riondato and Andrea Ciarmiello


DOI: 10.2174/1874471010666171101121803



Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings

, 2018; 11(1): 22-33.

Giulia Anna Follacchio*, Maria Silvia De Feo, Giuseppe De Vincentis, Francesco Monteleone and Mauro Liberatore


DOI: 10.2174/1874471011666171211161851


Letter to the Editor: International Consensus Radiochemistry Nomenclature Guidelines

, 2018; 11(1): 73-75.

Heinz H. Coenen*, Antony D. Gee*, Michael Adam, Gunnar Antoni, Cathy S. Cutler, Yasuhisa Fujibayashi, Jae Min Jeong, Robert H. Mach, Thomas L. Mindt, Victor W. Pike and Albert D. Windhorst


DOI: 10.2174/187447101101180404111248



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science